Already a winner of the RedDot Design Award2021, Gradientech has been awarded this year’s iF DESIGN AWARD for its QuickMIC diagnostic system for ultra-rapid antibiotic susceptibility testing. The iF DESIGN AWARD is granted to products with outstanding design.
Gradientech has been awarded the Red Dot Award: Product Design 2021 for its QuickMIC diagnostic system for ultra-rapid antibiotic susceptibility testing. The Red Dot Award is awarded to products that feature truly exceptional design.
Gradientech AB (publ) year-end report for 2020 is now available in Swedish on the company’s website www.gradientech.se.
Gradientech AB:s (publ) bokslutskommuniké för 2020 finns nu tillgänglig på bolagets hemsida www.gradientech.se.
Gradientech AB (publ) today announced that their QuickMIC system for rapid antibiotic susceptibility testing (AST) is currently being used for a beta test study by Uppsala University Hospital, Sweden.
Swedish diagnostics firm Gradientech is proud to announce the appointment of three internationally renowned members to the company’s scientific advisory board, SAB. With their expertise in clinical microbiology, the new advisors will provide valuable support in preparing for a successful market launch of Gradientech’s in vitro diagnostic system for ultra-rapid antibiotic susceptibility testing, claimed to be the fastest among new systems in development.
Gradientech AB (publ) interim report for Q3 2020 is now available in Swedish on the company’s website www.gradientech.se.
Gradientech AB (publ) delårsrapport för Q3 2020 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Gradientech AB (publ) delårsrapport för Q2 2020 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Innovative Swedish diagnostics company Gradientech announces closure of an oversubscribed financing round totalling $9 million (SEK 80 million). The round was executed by a combination of existing shareholders and several new investors appointed by Swedish financial advisor, Redeye. Bird & Bird Lawyers acted as legal advisors.